| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10174860 | Journal of American Association for Pediatric Ophthalmology and Strabismus | 2014 | 4 Pages |
Abstract
The Ozurdex implant in combination with systemic immunomodulatory therapy resulted in improved visual acuity, control of intraocular inflammation, and a decrease in corticosteroid use. In the majority of eyes the uveitis reoccurred around 4 months after injection. The adverse events in our study are similar to those identified in adult studies.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Monica L. MD, Yu-Guang MD, David R. MD,